Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-892-8 | CAS number: 706-14-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Study period:
- From 2002-04-26 to 2002-09-20
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP study conducted similarly to OECD test guideline No. 406 although not mentioned in the report. γ-Caprolactone, as aliphatic γ-lactone, is considered adequate for read-across purpose (see §"Toxicokinetics").
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 002
- Report date:
- 2002
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Principles of method if other than guideline:
- not applicable
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- At the time of study completion (2002), the LLNA OECD test method was not adopted.
Test material
- Reference substance name:
- Hexan-4-olide
- EC Number:
- 211-778-8
- EC Name:
- Hexan-4-olide
- Cas Number:
- 695-06-7
- IUPAC Name:
- 5-ethyldihydrofuran-2(3H)-one
- Test material form:
- liquid
- Details on test material:
- - Name of test material (as cited in study report): gamma-caprolactone
- Physical state: transparent liquid without color
- Storage condition of test material: room temperature in the dark
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Japan SLC, Inc.
- Age at study initiation: 5 weeks old
- Weight at study initiation: 297 to 328 g (preliminary study), 276 to 345 g (main study)
- Housing: 5 amimals / cage
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23+/-2
- Humidity (%): 50+/-10
- Air changes (per hr): 17 times/hr
- Photoperiod (hrs dark / hrs light): 12 hr/12 hr
IN-LIFE DATES: From: 2002-05-07 To: 2002-06-13
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- physiological saline
- Concentration / amount:
- Intradermal induction: 3.08% (Act. 3%).
Epicutaneous induction: undiluted (Act. 97.4%).
Challenge: undiluted (Act. 97.4%), 51.33% (Act. 50%), 30.80% (Act. 30%), 10.27% (Act. 10%), 5.13% (Act. 5%), 3.08% (Act.3%).
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- physiological saline
- Concentration / amount:
- Intradermal induction: 3.08% (Act. 3%).
Epicutaneous induction: undiluted (Act. 97.4%).
Challenge: undiluted (Act. 97.4%), 51.33% (Act. 50%), 30.80% (Act. 30%), 10.27% (Act. 10%), 5.13% (Act. 5%), 3.08% (Act.3%).
- No. of animals per dose:
- 5 females for intradermal treatment in preliminary study.
5 females for epicutaneous (occlusive) treatment in preliminary study.
10 females for treatment group in main study.
10 females for control group in main study. - Details on study design:
- PRELIMINARY STUDY
A. Topical application
Irritation assessment following 24h occlusive exposure to test material at 97.4, 50, 30, 10, 5 and 3% (Act.%); skin assessment 3, 24 and 48h after
removal of test substance.
Result: No skin irritation was observed in any concentration tested.
B. Intradermal
0.1 mL of test substance at 10, 5, 3, 1, 0.5, 0.3% (w/w) solution applied intradermally in physiological saline. Assessments was made 24, 48 and 72h post‐administration.
Result: necrosis was observed by 10 and 5% solution. Clear or slight erythema was observed by 3% solution, and this continued up to 72 hr. Slight erythema was observed by 1% solution, but disappeared within 72 hr. No skin reactions were observed by 0.5, 0.3 and 0% solutions.
MAIN STUDY
A. INDUCTION EXPOSURE
Day 0: Treatment group:
− Injection 1: 1:1 mixture (v/v) FCA/physiological saline
− Injection 2: 3% gamma-caprolactone in physiological saline
− Injection 3: 3% gamma-caprolactone in a 1:1 mixture (v/v) FCA/physiological saline
Control group:
- Injection 1: 1:1 mixture (v/v) FCA/physiological saline
- Injection 2: physiological saline
- Injection 3: 1:1 mixture (v/v) FCA/physiological saline
Day 7: Treatment group:
Region, free of fur, was treated topically with a 2 x 4 cm patch of Lint cloth, fully loaded with an undiluted of gamma-caprolactone (Act. 97.4%). Patch was covered by an occlusive bandage and left in place for 48 hours. Due to the non irritant potential of this substance, 10% SLS (Sodium Lauryl Sulfate) in vaseline was topically applied on Day 6 and wiped off on Day 7.
Control group:
Only vehicle (water for injection) was applied.
B. CHALLENGE EXPOSURE
Day 21: Flank of all animals, including controls, treated topically with 0.05 mL of undiluted (97.4%), 50%, 30%, 10%, 5%, 3% (w/w, Act.% in water for injection) test substance for 24h under an occlusive patch.
GRADING SYSTEM
Dermal reactions graded for erythema and edema according to grading scale by Draize:
No erythema: 0
Slight erythema: 1
Clear erythema: 2
Moderate to Severe erythema: 3
Severe erythema with scab: 4
No edema: 0
Slight edema: 1
Clear edema: 2
Moderate edema: 3
Severe edema: 4 - Challenge controls:
- Historical control: 2,4-dinitrochlorobenzene
- Positive control substance(s):
- yes
- Remarks:
- Historical control: 2,4-dinitrochlorobenzene
Results and discussion
- Positive control results:
- Sponsor confirmed that the sensitivity and reliability of the experimental technique used by the laboratory is regularly assessed using known sensitizer.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 97.4% to 3% in challenge
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 97.4% to 3% in challenge. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 0. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 97.4 to 3% in challenge
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 97.4 to 3% in challenge. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 0. No with. + reactions: 0.0. Total no. in groups: 10.0.
Any other information on results incl. tables
none
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The test material, γ-Caprolactone, is not classified as skin sensitiser under the test conditions .
- Executive summary:
In a dermal sensitisation study performed according to Japanese guideline for medicines (similar to OECD test guideline No. 406) and in compliance with GLP, γ-Caprolactone was tested in female Hartley guinea-pigs using the Guinea-Pig Maximisation Test method (10 treated animals + 10 controls).
The preliminary study determined the concentration to be used for the induction and challenge phases of the main study.
In study Day 0, induction was performed by intradermally injecting 0.1 mL of each 1:1 mixture (v/v) FCA/physiological saline, 3% γ-Caprolactone in physiological saline, and 3% γ-caprolactone in a 1:1 mixture (v/v) FCA/physiological saline. In study Day 7, undiluted of γ-Caprolactone (Act. 97.4%) was patched for 48 hr occlusively. In the absence of irritant potential of this substance, 10% SLS (Sodium Lauryl Sulfate) in vaseline was topically applied on Day 6 and wiped off on Day 7. In study Day 21, challenge was performed by treated topically with 0.05 mL of undiluted (97.4%), 50%, 30%, 10%, 5%, 3% (w/w, Act.% in water for injection) test substance for 24h under an occlusive condition.
In this study, no skin reaction was observed in test group and control group.
Sponsor confirmed that the sensitivity and reliability of the experimental technique used by the laboratory is regularly assessed using known sensitizer.
Based on the overall sensitisation rate, γ-Caprolactone is not classified as skin sensitiser according to the Directive 67/548/EEC and the Regulation EC No. 1272/2008 (CLP).
This study is considered as acceptable and satisfies the requirement for skin sensitisation endpoint.
γ-Caprolactone, as aliphatic γ-lactone, is considered adequate for read-across purpose (see §"Toxicokinetics).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.